KRAS MUTATION CODON 12 & 13
207 Ratings
Rs 10,125 Rs 7,500
26 % OFF
KRAS MUTATION TESTING IS RECOMMENDED PRIOR TO INITIATION OF EGFR TARGETED THERAPY IN COLORECTAL CARCINOMA. ABSENCE OF DETECTABLE KRAS MUTATION WITHIN THE TUMOR SUGGESTS THAT THIS PATIENT MAY RESPOND TO SUCH THERAPIES.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
SUBMIT FORMALIN FIXED PARAFFIN EMBEDDED TISSUE BLOCK. SHIP AT ROOM TEMPERATURE. BLOCK SHOULD HAVE AT LEAST 10% TUMOR TISSUE. DULY FILLED NGS TEST REQUISITION FORM (FORM 40) IS MANDATORY.
PCR, FRAGMENT ANALYSIS
REPORT ON 15TH DAY EVENING 7PM
DULY FILLED NGS TEST REQUISITION FORM (FORM 40) IS MANDATORY.
